Kiwi Wealth Investments Limited Partnership Novo Nordisk A S Transaction History

Kiwi Wealth Investments Limited Partnership

$126 Million
Q4 2023

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2019 Nov 13, 2019	SELL	$47.54 - $53.43 $4 Million - $4.49 Million	-84,073 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$46.79 - $52.47 $3.93 Million - $4.41 Million	84,073 New	84,073 $4.29 Million

Others Institutions Holding NVO

# of Institutions

1,879

Shares Held

317M

Call Options Held

5.49M

Put Options Held

7.77M

Jennison Associates LLC

19.9M
Shares

$1.68 Billion
1.06% of portfolio
Morgan Stanley New York, NY

14.4M
Shares

$1.21 Billion
0.13% of portfolio
Bank Of America Corp Charlotte, NC

14.3M
Shares

$1.2 Billion
0.14% of portfolio
Ken Fisher Fisher Asset Management, LLC | Camas, Wa

13.3M
Shares

$1.12 Billion
0.65% of portfolio
Fayez Sarofim & CO Houston, TX

12.2M
Shares

$1.03 Billion
3.76% of portfolio

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $190B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Kiwi Wealth Investments Limited Partnership, based on Form 13F filings with the SEC.

News

Stay updated on Kiwi Wealth Investments Limited Partnership with notifications on news.

Account